Anti-tumor necrosis factor alpha treatment with adalimumab improves significantly endothelial function and decreases inflammatory process in patients with chronic psoriasis

被引：48

作者：

Avgerinou, Georgia ^{[2
]}

Tousoulis, Dimitris ^{[1
]}

Siasos, Gerasimos ^{[1
]}

Oikonomou, Evaggelos ^{[1
]}

Maniatis, Konstantinos ^{[1
]}

Papageorgiou, Nikolaos ^{[1
]}

Paraskevopoulos, Theodoros ^{[1
]}

Miliou, Antigoni ^{[1
]}

Koumaki, Dimitra ^{[2
]}

Latsios, George ^{[1
]}

Therianiou, Anastasia ^{[1
,2
]}

Trikas, Athanasios ^{[1
]}

Kampoli, Anna Maria ^{[1
]}

Stefanadis, Christodoulos ^{[1
]}

机构：

[1] Univ Athens, Sch Med, Hippokrat Hosp, Cardiol Unit 1, Athens 11528, Greece

[2] Univ Athens, Dept Dermatol 1, A Sygros Hosp, Athens 11528, Greece

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2011年 / 151卷 / 03期

关键词：

Inflammation; Adalimumab; Psoriasis; Endothelium; REPORTED OUTCOMES; TRIAL; RISK;

D O I：

10.1016/j.ijcard.2011.06.112

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：382 / 383

页数：2

共 50 条

[21] Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn's Disease Is Not Associated with Emergence of Novel Inflammatory Pathways [J].

Luther, Jay ;

Gala, Manish ;

Patel, Suraj J. ;

Dave, Maneesh ;

Borren, Nynke ;

Xavier, Ramnik J. ;

Ananthakrishnan, Ashwin N. .

DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (03) :738-745

[22] Management of Inflammatory Bowel Disease with Infliximab and Other Anti-Tumor Necrosis Factor Alpha Therapies [J].

Fernando Magro ;

Francisco Portela .

BioDrugs, 2010, 24 :3-14

[23] Anti-Tumor Necrosis Factor Alpha Antibodies for Remission Maintenance Therapy in Inflammatory Bowel Disease [J].

Neubauer, Katarzyna ;

Kempinski, Radoslaw ;

Poniewierka, Elzbieta .

ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 19 (02) :143-149

[24] Anti-Tumor Necrosis Factor Alpha Therapeutic Drug Monitoring in Inflammatory Disease: A Systematic Review [J].

Schneider, Caralin ;

Stratman, Scott ;

Choragudi, Siri ;

Lev-Tov, Hadar .

JOURNAL OF DRUGS IN DERMATOLOGY, 2023, 22 (05) :445-450

[25] Management of Inflammatory Bowel Disease with Infliximab and Other Anti-Tumor Necrosis Factor Alpha Therapies [J].

Magro, Fernando ;

Portela, Francisco .

BIODRUGS, 2010, 24 :3-14

[26] Relapse rates of inflammatory bowel disease patients in deep and clinical remission after discontinuing anti-tumor necrosis factor alpha therapy [J].

Hlavaty, T. ;

Krajcovicova, A. ;

Letkovsky, J. ;

Sturdik, I ;

Koller, T. ;

Toth, J. ;

Huorka, M. .

BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2016, 117 (04) :205-211

[27] Effects of Anti-Tumor Necrosis Factor Therapy on Body Composition and Insulin Sensitivity in Patients With Psoriasis [J].

Kofoed, Kristian ;

Clemmensen, Anders ;

Mikkelsen, Ulla R. ;

Simonsen, Lene ;

Andersen, Ove ;

Gniadecki, Robert .

ARCHIVES OF DERMATOLOGY, 2012, 148 (09) :1089-1091

[28] Effect of anti-tumor necrosis factor-α therapies on body mass index in patients with psoriasis [J].

Saraceno, Rosita ;

Schipani, Caterina ;

Mazzotta, Annamaria ;

Esposito, Maria ;

Di Renzo, Laura ;

De Lorenzo, Antonino ;

Chimenti, Sergio .

PHARMACOLOGICAL RESEARCH, 2008, 57 (04) :290-295

[29] Chronic Ulcer on the Tongue as a Manifestation of Histoplasmosis During Anti-tumor Necrosis Factor-Alpha (TNF-α) Inhibitor Therapy for Psoriasis [J].

Harrison, Iris ;

Forouzandeh, Mahtab ;

Motaparthi, Kiran .

CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)

[30] Risk of consecutive immunogenic failure in switchers of anti-tumor necrosis factor alpha among patients with inflammatory bowel diseases [J].

Yanai, Henit ;

Ungar, Bella ;

Kopylov, Uri ;

Fischler, Tali Sharar ;

Biron, Irit Avni ;

Ollech, Jacob E. ;

Goren, Idan ;

Matar, Manar ;

Perets, Tsachi Tsadok ;

Shamir, Raanan ;

Dotan, Iris ;

Amir, Shira ;

Assa, Amit .

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15

← 1 2 3 4 5 →